A Practitioner's Guide to Probiotics: Neurological Conditions

Probiotic supplements contain beneficial microorganisms, similar to those found in the human gastrointestinal tract (79). When ingested, these live microorganisms confer a number of health benefits to the host (22). Particular strains of probiotics can provide neuroactive properties that may induce effects on the human brain, mind, and behavior. These kinds of probiotics are often referred to as psychobiotics (52).

Imbalances in the intestinal microbiota are believed to be involved in the development of certain neurological disorders and may modulate other affective and behavioral responses from the central nervous system (CNS). The signalling that takes place between the GI system and the CNS, the neuroendocrine system, the neuroimmune system, the sympathetic and parasympathetic autonomic nervous systems, and the enteric nervous system is commonly referred to as the gut-brain axis (9, 68). 

Probiotic supplements may support a healthy composition of bacteria in the gastrointestinal tract and improve cognitive and behavioral function by a number of mechanisms, including:

  • Modulation of neurotransmitters, such as norepinephrine, serotonin, acetylcholine, and corticotropin releasing factor, involved in the gut-brain axis
  • Metabolite conversion in regulation of the immune and nervous systems
  • Modulation of microbial metabolites and inflammatory cytokines that stimulate the vagus nerve
  • Downregulation of proinflammatory cytokines through anti-inflammatory modulation
  • Modulation of the HPA axis, hormones, and receptors (eg. GABA, opioid-μ, cannabinoid)
  • Prevention of dendritic atrophy, promotion of synaptic connections, and neurogenesis
  • Production of short-chain fatty acids (SCFAs) that can cross the blood-brain barrier and induce neuroprotective, cognitive, and antidepressant effects (9)

While probiotics are now commonly prescribed therapeutically and clinical research examining the relationship between the gut microbiome and neurological disorders is becoming increasingly available (55), clear guidelines for clinical application have yet to be established. This is particularly important as the effectiveness of probiotic supplementation may be dependent on the condition, strain, dosing, and duration of therapy (79). 

This guide provides an overview of the available research for the clinical application of probiotics in neurological conditions, including dosing and administration for single-strain and multi-strain probiotics.

Download the full guide to probiotics in neurological conditions.

Safety Considerations & Contraindications

While probiotics are considered safe, rare short term side effects, such as gas and bloating, may occur (15). Isolated cases of bacteremia or fungemia have been associated with probiotics, though population data also indicates that there is no widespread risk of these complications (66). 

There is some limited evidence that probiotics should not be administered in critically ill patients, as demonstrated by an increased risk of mesenteric ischemia and mortality in a trial of patients with predicted severe acute pancreatitis (8).

  1. Agrawal, A., Sharma, B. C., Sharma, P., & Sarin, S. K. (2012). Secondary prophylaxis of hepatic encephalopathy in cirrhosis: An open-label, randomized controlled trial of lactulose, probiotics, and no therapy. American Journal of Gastroenterology, 107(7), 1043–1050.
  2. Akbari, E., Asemi, Z., Kakhaki, R. D., Bahmani, F., Kouchaki, E., Tamtaji, O. R., … Salami, M. (2016). Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind and controlled trial. Frontiers in Aging Neuroscience, 8.
  3. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., … Esmaillzadeh, A. (2016). Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition, 32(3), 315–320.
  4. Allen, A. P., Hutch, W., Borre, Y. E., Kennedy, P. J., Temko, A., Boylan, G., … Clarke, G. (2016). Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Translational Psychiatry, 6(11).
  5. Bagga, D., Reichert, J. L., Koschutnig, K., Aigner, C. S., Holzer, P., Koskinen, K., … Schöpf, V. (2018). Probiotics drive gut microbiome triggering emotional brain signatures. Gut Microbes, 9(6), 486–496.
  6. Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., Puri, P., Sterling, R. K., … Gillevet, P. M. (2014). Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Alimentary Pharmacology & Therapeutics, 39(10), 1113–1125.
  7. Benton, D., Williams, C., & Brown, A. (2006). Impact of consuming a milk drink containing a probiotic on mood and cognition. European Journal of Clinical Nutrition, 61(3), 355–361.
  8. Besselink, M.G., van Santvoort, H.C., Buskens, E., Boermeester, M.A., van Goor, H., Timmerman, H.M., … Gooszen, H.G. (2008). Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet, 371(9613), 651-659.
  9. Bermúdez-Humarán, L. G., Salinas, E., Ortiz, G. G., Ramirez-Jirano, L. J., Morales, J. A., & Bitzer-Quintero, O. K. (2019). From probiotics to psychobiotics: Live beneficial bacteria which act on the brain-gut axis. Nutrients, 11(4), 890.
  10. Borzabadi, S., Oryan, S., Eidi, A., Aghadavod, E., Kakhaki, R. D., Tamtaji, O. R., & Asemi, Z. (2018). The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with parkinson’s disease: A randomized, double-blind, placebo controlled trial. Archives of Iranian Medicine, 21(7), 289–295.
  11. Cao, Q., Yu, C., Yang, S., Cao, H., Chen, P., Deng, M., & Li, L. (2018). Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis. Hepatobiliary & Pancreatic Diseases International, 17(1), 9–16.
  12. Cassani, E., Privitera, G., Pezzoli, G., Pusani, C., Madio, C., Iorio, L., & Barichella, M. (2011). Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterologica e Dietologica, 57(2), 117–121.
  13. Ceccarelli, G., Fratino, M., Selvaggi, C., Giustini, N., Serafino, S., Schietroma, I., & d’Ettorre, G. (2017). A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA‐29a‐c levels in antiretroviral‐treated HIV‐1‐infected patients. Brain and Behavior, 7(8), e00756.
  14. Chong, H.X., Yusoff, N.A.A., Hor, Y.Y., Lew, L.C., Jaafar, M.H., Choi, S.B., … Liong, M.T. (2019). Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study. Beneficial Microbes, 10(4), 355-373.
  15. Ciorba M. A. (2012). A gastroenterologist’s guide to probiotics. Clinical Gastroenterology and Hepatology, 10(9), 960–968. 
  16. Colica, C., Avolio, E., Bollero, P., Miranda, R. C. D., Ferraro, S., Salimei, P. S., … Renzo, L. D. (2017). Evidences of a new psychobiotic formulation on body composition and anxiety. Mediators of Inflammation, 2017, 1–10.
  17. Culpepper, T., Christman, M.C., Nieves, C.Jr., Specht, G.J., Rowe, C.C., Spaiser, S.J., … Langkamp-Henken, B. (2016). Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: A secondary analysis of a randomised trial. Beneficial Microbes, 7(3), 327-36. 
  18. Dhiman, R. K., Thumburu, K. K., Verma, N., Chopra, M., Rathi, S., Dutta, U., … Singh, M. (2019). Comparative efficacy of treatment options for minimal hepatic encephalopathy: A systematic review & network meta-analysis. Clinical Gastroenterology and Hepatology, S1542–S3565.
  19. Dickerson, F. B., Stallings, C., Origoni, A., Katsafanas, E., Savage, C. L. G., Schweinfurth, L. A. B., … Yolken, R. H. (2014). Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning. The Primary Care Companion For CNS Disorders, 16(1).
  20. Dickerson, F., Adamos, M., Katsafanas, E., Khushalani, S., Origoni, A., Savage, C., … Yolken, R. H. (2018). Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial. Bipolar Disorders, 20(7), 614–621.
  21. Diop, L., Guillou, S., & Durand, H. (2008). Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: A double-blind, placebo-controlled, randomized trial. Nutrition Research, 28(1), 1-5. 
  22. Fijan, S. (2014). Microorganisms with claimed probiotic properties: An overview of recent literature. International Journal of Environmental Research and Public Health, 11(5), 4745–4767.
  23. Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D. (2016). Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: Is there hope? Clinical Interventions in Aging, 11, 1601–1608.
  24. Groeger, D., O’Mahony, L., Murphy, E. F., Bourke, J. F., Dinan, T. G., Kiely, B., … Quigley, E. M. (2013). Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes, 4(4), 325–339.
  25. Holte, K., Krag, A., & Gluud, L. L. (2012). Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatology Research, 42(10), 1008–1015.
  26. Hwang, Y., Park, S., Paik, J., Chae, S., Kim, D., Jeong, D., … Chung, Y.. (2019). Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: A 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients, 11(2), 305.
  27. Kato-Kataoka, A., Nishida, K., Takada, M., Kawai, M., Kikuchi-Hayakawa, H., Suda, K., … Rokutan, K. (2016). Fermented milk containing Lactobacillus casei strain Shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Applied and Environmental Microbiology, 82(12), 3649–3658. 
  28. Kato-Kataoka, A., Nishida, K., Takada, M., Suda, K., Kawai, M., Shimizu, K., … Rokutan K. (2016). Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress. Beneficial Microbes, 7(2), 153-6.
  29. Kazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019). Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clinical Nutrition, 38(2), 522–528.
  30. Kirpich, I. A., Solovieva, N. V., Leikhter, S. N., Shidakova, N. A., Lebedeva, O. V., Sidorov, P. I., … Cave, M. (2008). Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol, 42(8), 675–682.
  31. Kobayashi, Y., Kuhara, T., Oki, M., & Xiao, J.-Z. (2019). Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: A randomised, double-blind, placebo-controlled trial. Beneficial Microbes, 10(5), 511–520.
  32. Langkamp-Henken, B., Rowe, C.C., Ford, A.L., Christman, M.C., Nieves, C.Jr., Khouri, L., … Dahl, W.J. (2015). Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: A randomised, double-blind, placebo-controlled study. British Journal of Nutrition, 113(3), 426-34. 
  33. Leblhuber, F., Steiner, K., Schuetz, B., Fuchs, D., & Gostner, J. M. (2018). Probiotic supplementation in patients with Alzheimer’s dementia – An explorative intervention study. Current Alzheimer Research, 15(12), 1106–1113.
  34. Liu, Y., Liong, M. T., Chung, Y. E., Huang, H., Peng, W., Cheng, Y., … Tsai, Y. (2019). Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: A randomized, double-blind, placebo-controlled trial. Nutrients, 11(4), 820.
  35. Loguercio, C., Blanco, C. D. V., & Coltorti, M. (1987). Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: A controlled study. Journal of International Medical Research, 15(6), 335–343.
  36. Loguercio, C., Abbiati, R., Rinaldi, M., Romano, A., Blanco, C. D. V., & Coltorti, M. (1995). Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1–2 hepatic encephalopathy. Journal of Hepatology, 23(1), 39–46.
  37. Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S., & Srivastava, S. (2014). Probiotics prevent hepatic encephalopathy in patients with cirrhosis: A randomized controlled trial. Clinical Gastroenterology and Hepatology, 12(6), 1003–1008.
  38. Majeed, M., Nagabhushanam, K., Arumugam, S., Majeed, S., & Ali, F. (2018). Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: A randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food & Nutrition Research, 62.
  39. Marotta, A., Sarno, E., Del Casale, A., Pane, M., Mogna, L., Amoruso, A., … Fiorio, M. (2019). Effects of probiotics on cognitive reactivity, mood, and sleep quality. Frontiers in Psychiatry, 10, 164. 
  40. McKean, J., Naug, H., Nikbakht, E., Amiet, B., & Colson, N. (2017). Probiotics and subclinical psychological symptoms in healthy participants: A systematic review and meta-analysis. Journal of Alternative and Complementary Medicine, 23(4), 249-258.
  41. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., … Cazaubiel, J.M. (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition, 105(5), 755-64.
  42. Mittal, V. V., Sharma, B. C., Sharma, P., & Sarin, S. K. (2011). A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. European Journal of Gastroenterology & Hepatology, 23(8), 725–732.
  43. Miyaoka, T., Kanayama, M., Wake, R., Hashioka, S., Hayashida, M., Nagahama, M., … Horiguchi, J. (2018). Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder. Clinical Neuropharmacology, 41(5), 151–155.
  44. Mohammadi, A.A., Jazayeri, S., Khosravi-Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., … Eghtesadi, S. (2016). The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutritional Neuroscience, 19(9), 387-395.
  45. Monoi, N., Matsuno, A., Nagamori, Y., Kimura, E., Nakamura, Y., Oka, K., … Urade, Y. (2016). Japanese sake yeast supplementation improves the quality of sleep: a double-blind randomised controlled clinical trial. Journal of Sleep Research, 25(1), 116-23.
  46. Mouli, V. P., Benjamin, J., Singh, M. B., Mani, K., Garg, S. K., Saraya, A., & Joshi, Y. K. (2014). Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatology Research, 45(8), 880–889.
  47. Ng, Q. X., Peters, C., Ho, C. Y. X., Lim, D. Y., & Yeo, W. (2018). A meta-analysis of the use of probiotics to alleviate depressive symptoms. Journal of Affective Disorders, 228, 13–19.
  48. Ng, Q. X., Soh, A. Y. S., Venkatanarayanan, N., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2019). A systematic review of the effect of probiotic supplementation on Schizophrenia symptoms. Neuropsychobiology, 78(1), 1–6.
  49. Nikolova, V., Zaidi, S. Y., Young, A. H., Cleare, A. J., & Stone, J. M. (2019). Gut feeling: Randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology, 9, 204512531985996.
  50. Nishida, K., Sawada, D., Kawai, T., Kuwano, Y., Fujiwara, S., & Rokutan, K. (2017). Para-psychobiotic Lactobacillus gasseri CP2305 ameliorates stress-related symptoms and sleep quality. Journal of Applied Microbiology, 123(6). 1561-1570. 
  51. Okubo, R., Koga, M., Katsumata, N., Odamaki, T., Matsuyama, S., Oka, M., … Matsuoka, Y. J. (2019). Effect of Bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. Journal of Affective Disorders, 245, 377–385.
  52. Oleskin, A. V., & Shenderov, B. A. (2019). Probiotics and psychobiotics: the role of microbial neurochemicals. Probiotics and Antimicrobial Proteins. 
  53. Parracho, H. M. R. T., Gibson, G. R., Knott, F., Bosscher, D., Kleerebezem, M., & McCartney, A. L. (2010). A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorder. International Journal of Probiotics and Prebiotics, 5(2), 69–74.
  54. Pärtty, A., Kalliomäki, M., Wacklin, P., Salminen, S., & Isolauri, E. (2015). A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatric Research, 77(6), 823–828.
  55. Roman, P., Abalo, R., Marco, E. M., & Cardona, D. (2018). Probiotics in digestive, emotional, and pain-related disorders. Behavioural Pharmacology, (2-3), 103–119.
  56. Roman, P., Carrillo-Trabalón, F., Sánchez-Labraca, N., Cañadas, F., Estévez, A., & Cardona, D. (2018). Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Beneficial Microbes, 9(4), 603–611.
  57. Roman, P., Estévez, A. F., Miras, A., Sánchez-Labraca, N., Cañadas, F., Vivas, A. B., & Cardona, D. (2018). A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Scientific Reports, 8(1).
  58. Saab, S., Suraweera, D., Au, J., Saab, E. G., Alper, T. S., & Tong, M. J. (2015). Probiotics are helpful in hepatic encephalopathy: A meta-analysis of randomized trials. Liver International, 36(7), 986–993.
  59. Sawada, D., Kawai, T., Nishida, K. Kuwano, Y., Fujiwara, S., & Rokutan, K. (2017). Daily intake of Lactobacillus gasseri CP2305 improves mental, physical, and sleep quality among Japanese medical students enrolled in a cadaver dissection course. Journal of Functional Foods, 31, 188-197. 
  60. Severance, E. G., Gressitt, K. L., Stallings, C. R., Katsafanas, E., Schweinfurth, L. A., Savage, C. L., … Yolken, R. H. (2017). Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study. Brain, Behavior, and Immunity, 62, 41–45.
  61. Shaaban, S. Y., Gendy, Y. G. E., Mehanna, N. S., El-Senousy, W. M., El-Feki, H. S. A., Saad, K., & El-Asheer, O. M. (2017). The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutritional Neuroscience, 21(9), 676–681.
  62. Sharma, P., Sharma, B. C., Puri, V., & Sarin, S. K. (2008). An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. European Journal of Gastroenterology & Hepatology, 20(6), 506–511.
  63. Sharma, K., Pant, S., Misra, S., Dwivedi, M., Misra, A., Narang, S., … Bhadoria, A. (2014). Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial. Saudi Journal of Gastroenterology, 20(4), 225–232.
  64. Shavakhi, A., Hashemi, H., Tabesh, E., Derakhshan, Z., Farzamnia, S., Meshkinfar, S., & Gholamrezaei, A. (2014). Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy. Journal of Research in Medical Sciences, 19(8), 703–708.
  65. Slykerman, R. F., Hood, F., Wickens, K., Thompson, J. M., Barthow, C., Murphy, R., & Mitchell, E. A. (2017). Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum symptoms of depression and anxiety: A randomised double-blind placebo-controlled trial. EBioMedicine, 24, 159–165.
  66. Snydman, D.R. (2008). The safety of probiotics. Clinical Infectious Diseases, 46(Suppl 2), S104-11. 
  67. Steenbergen, L., Sellaro, R., Hemert, S. V., Bosch, J. A., & Colzato, L. S. (2015). A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behavior, and Immunity, 48, 258–264.
  68. Stefano, G. B., Ptacek, R., Raboch, J., & Kream, R. M. (2017). Microbiome: A potential component in the origin of mental disorders. Medical Science Monitor, 23, 3039–3043.
  69. Sullivan, Å., Nord, C. E., & Evengård, B. (2009). Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutrition Journal, 8(1).
  70. Takada, M., Nishida, K., Gondo, Y., Kikuchi-Hayakawa, H., Ishikawa, H., Suda, K., … Rokutan, K. (2017). Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blind, randomised, placebo-controlled trial. Beneficial Microbes, 8(2), 153-162. 
  71. Takada, M., Nishida, K., Kataoka-Kato, A., Gondo, Y., Ishikawa, H., Suda, K., … Rokutan, K. (2016). Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterology & Motility, 28(7), 1027-36.
  72. Tamtaji, O. R., Taghizadeh, M., Kakhaki, R. D., Kouchaki, E., Bahmani, F., Borzabadi, S., … Asemi, Z. (2019). Clinical and metabolic response to probiotic administration in people with Parkinsons disease: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 38(3), 1031–1035.
  73. Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., … Weiner, H. L. (2018). Investigation of probiotics in multiple sclerosis. Multiple Sclerosis Journal, 24(1), 58–63.
  74. Tankou, S. K., Regev, K., Healy, B. C., Tjon, E., Laghi, L., Cox, L. M., … Weiner, H. L. (2018). A probiotic modulates the microbiome and immunity in multiple sclerosis. Annals of Neurology, 83(6), 1147–1161.
  75. Tomasik, J., Yolken, R. H., Bahn, S., & Dickerson, F. B. (2015). Immunomodulatory effects of probiotic supplementation in schizophrenia patients: A randomized, placebo-controlled trial. Biomarker Insights, 10, 47–54.
  76. Venket Rao, A., Bested, A. C., Beauline, T. M., Katzman, M. A., Iorio, C., Berardi, J. M., & Logan, A. C. (2009). A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens, 1(6).
  77. Vlachogiannakos, J., Vasianopoulou, P., Viazis, N., Chroni, M., Karamanolis, D., & Ladas, S. (2016). Reversal of minimal hepatic encephalopathy after a probiotic administration. A prospective, randomized, placebo-controlled, double-blind study. Journal of Hepatology, 64(2), S165.
  78. West, R., Roberts, E., Sichel, L. S., & Sichel, J. (2013). Improvements in gastrointestinal symptoms among children with autism spectrum disorder receiving the Delpro® probiotic and immunomodulator formulation. Probiotics & Health, 1(1), 1–6.
  79. Wilkins, T., & Sequoia, J. (2017). Probiotics for gastrointestinal conditions: A summary of the evidence. American Family Physician, 96(3), 170–178.
  80. Xia, X., Chen, J., Xia, J., Wang, B., Liu, H., Yang, L., … Ling, Z. (2018). Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. Journal of International Medical Research, 46(9), 3596–3604.
  81. Xu, J., Ma, R., Chen, L., Zhao, L., Chen, K., & Zhang, R. (2014). Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary & Pancreatic Diseases International, 13(4), 354–360.
  82. Yamamura, S., Morishima, H., Kumano-go, T., Suganuma, N., Matsumoto, H., Adachi, H., …Takeda, M. (2009). The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjects. European Journal of Clinical Nutrition, 63(1), 100-5.
  83. Zhao, L., Yu, T., Lan, S., Hou, J., Zhang, Z., Wang, S., & Liu, F. (2015). Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis. Clinics and Research in Hepatology and Gastroenterology, 39(6), 674–682.
  84. Ziada, D. H., Soliman, H. H., Yamany, S. A. E., Hamisa, M. F., & Hasan, A. M. (2013). Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy. Arab Journal of Gastroenterology, 14(3), 116–122.